References:

［1］Bawa H，Weick JW，Dirschl DR,et al.Trends in deep vein thrombosis prophylaxis and deep vein thrombosis rates after total hip and knee arthroplasty[J].J Am Acad Orthop Surg,2018,26(19):698-705.
［2］Millar JS，Lawes CM，Farrington B，et al.Incidence of venous thromboembolism after total hip，total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit[J].N Z Med J,2020,133(1511):52-60.
［3］Kim JS.Deepvein thrombosis prophylaxis after total hip arthroplasty in Asian patients[J].Hip Pelvis,2018,30(4):197-201.
［4］刘斐,徐凯,卫大宁,等.深静脉血栓筛查在膝关节置换术中的临床意义[J].血栓与止血学,2021,27(1):110-111.
［5］孙晓颖.早期功能锻炼及健康教育护理干预对中老年膝关节置换术后下肢深静脉血栓形成的预防作用[J].血栓与止血学,2021,27(1):161-162.
［6］高洁,赵春梅.护理干预结合气压泵治疗对预防髋关节置换术后下肢深静脉血栓形成的效果评价[J].血栓与止血学,2021,27(2):358-360.
［7］Rexiti P，Wutiku M，Wulamu W,et al.Pulmonary hypertension could be a risk for deep vein thrombosis in lower extremities after joint replacement surgery[J].Rev Assoc Med Bras (1992),2019,65(7):946-950.
［8］Xu H，Zhang S，Xie J，et al.A nested case-control study on the risk factors of deep vein thrombosis for Chinese after total joint arthroplasty[J].J Orthop Surg Res,2019,14(1):188.
［9］Glassberg MB，Lachiewicz PF.Changing patterns of anticoagulation after total hip arthroplasty in the United States：Frequency of deep vein thrombosis，pulmonary embolism，and complications with rivaroxaban and warfarin[J].J Arthroplasty,2019,34(8):1793-1801.
［10］Wiznia DH，Swami N，Nguyen J，et al.Patient compliance with deep vein thrombosis prophylaxis after total hip and total knee arthroplasty[J].Hematol Rep,2019,11(2):7914.
［11］Lu X，Lin J.Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery：a systematic review and meta-analysis[J].BMC Musculoskelet Disord,2018,19(1):322.
［12］方晴,刘继华,董博,等.血府逐瘀汤联合低分子肝素钙预防全髋关节置换术后深静脉血栓[J].吉林中医药,2018,38(9):1030-1033.
［13］简功辉,李冬春,黄永松,等.王勇教授治疗创伤性深静脉血栓的学术经验[J].中国中医急症,2017,26(5):809-811.
［14］靖金鹏,张玥,刘效敏,等.补阳还五汤预防骨科术后深静脉血栓形成的系统评价及试验序贯分析[J].中国组织工程研究,2021,25(20):3267-3274.
［15］陈红,王维,李配富,等.红藤联合脉通散外敷对肺癌伴下肢深静脉血栓患者血液流变学及血栓弹力图的影响[J].中国医药导报,2020,17(5):156-159.
［16］回雪颖,郭伟光,滕林,等.下肢深静脉血栓形成的中医研究进展[J].中医药学报,2020,48(5):66-69.
［17］顾玉彪,冯辉,郑林,等.加味血府逐瘀汤联合利伐沙班对全膝关节置换术后深静脉血栓发生的影响[J].中医杂志,2018,59(18):1578-1582.
［18］刘松,韦标方,肖伯莲,等.加味桃红四物汤联合冰消散外敷治疗老年性股骨头坏死全髋关节置换术后下肢肿胀30例[J].现代中医药,2018,38(6):54-56.
［19］曾焘,高大伟,吴宇峰,等.中医药预防骨科术后下肢深静脉血栓随机对照试验的Meta分析[J].世界中西医结合杂志,2019,14(12):1657-1660,1665.
［20］李永耀,程灏,关继超,等.中药联合肝素预防老年髋部骨折深静脉血栓的临床研究[J].中国中西医结合外科杂志,2017,23(2):174-177.
［21］梁治权,张凯.舒筋活血汤联合低分子肝素对髋关节置换术老年患者血液相关指标和肿痛情况、DVT发生率的影响[J].陕西中医,2018,39(10):1432-1434.
［22］屈远新,黄志虎.舒筋活络汤加减联合肝素抗凝对髋关节置换术后凝血功能的影响[J].现代中西医结合杂志,2016,(4):413-415.
［23］高瑞红,高玉军.舒筋活血汤联合低分子肝素对髋关节置换术患者DVT形成、Harris评分及运动功能的影响[J].贵州医药,2020,44(3):428-430.
［24］伍冬庆,侯怡翔,陈燕青.舒筋活血汤联合中医推拿对人工全膝关节置换术后患者康复的影响[J].现代中西医结合杂志,2020,29(4):415-419.
［25］孙凯,马方.舒筋活血汤联合抗凝治疗在踝关节骨折围术期及术后的应用观察[J].检验医学与临床,2020,17(21):3192-3194.